click below
click below
Normal Size Small Size show me how
pharm ch. 27
coagulation modifiers
| Question | Answer |
|---|---|
| anticoagulants | heparin & warfarin sodium (Coumadin) |
| anticoagulants | given prophylactically |
| anticoagulants | (blank) |
| thrombus | pre-formed clot |
| embolus | clot formed on the wall of a blood vess- that dislodges and travels through system |
| DVT | embolus that had traveled to the veins in the legs |
| warfarin sodium (Coumadin) MOA | works by inhibiting certain clotting factors-- factors that rely heavily onvet. Kfor theri synthesis. |
| heparin MOA | binds to antithrombin III which turns off three main activating factos |
| warfarin sodium (Coumadin) and heparin Indication | MI, unstastable angina, atrial febrillation, indwellng devices( mech heart valves) major orhtopedic surgery |
| warfarin sodium (Coumadin) and heparin Indication | leukemia, pregnancy, GI obstruction, and serious inflammation |
| heparin SE | thrombocytopenia |
| warafin SE | Alopecia, urticaria, dermatitis, nausea |
| Plavix (clopidogrel ) MOA | inhibits platelet aggreagatoin by altering the paltetl membrane so that it can no lnger recieve the signal to aggreage and forma clot. -- better than aspirin at reducing the number of heart attacck, strokes an vasucalt death. |
| Plavix SE | Headache, dizziness, rash |
| Aspirin interaction | given with NSAIDS can potientate bleeding |
| aspirin contraindication | aspirin blocks vitamin K-- can cause stomach and GI bleeding |
| thromboylytics ( streptokinase) | break down pre-formed clots in coronary arteris to prevent a myocardial infarction |
| thromboylytics ( streptokinase) MOA | breaks binds with plaminogen to form an SK plasminogen complex = forms plasmin= lyses the clots. |
| thromboylytics ( streptokinase) SE | internal,intracranial, and superificial bleeding |
| heparin activated partial thromboplastin time (APTT) | 1.5-2 times the control value |